• 1. Emerging investigator series: bacteriophages as nano engineering tools for quality monitoring and pathogen detection in water and wastewater
  Fereshteh Bayat Environ. Sci.: Nano, 2021,8, 367-389
• 2. Exciting clusters, what does off-resonance actually mean??
  Goonay Yousefalizadeh,Shideh Ahmadi,Nicholas J. Mosey,Kevin G. Stamplecoskie Nanoscale, 2021,13, 242-252
• 3. Excited-state proton-coupled electron transfer within ion pairs?
  Gerald J. Meyer,Leif Hammarstr?m Chem. Sci., 2020,11, 3460-3473
• 4. Exceptional activity of sub-nm Pt clusters on CdS for photocatalytic hydrogen production: a combined experimental and first-principles study?
  Qiyuan Wu,Shangmin Xiong,Peichuan Shen,Shen Zhao,Alexander Orlov Catal. Sci. Technol., 2015,5, 2059-2064
• 5. Empowering microfluidics by micro-3D printing and solution-based mineral coating?
  Hongxia Li,Aikifa Raza,Qiaoyu Ge,Jin-You Lu,TieJun Zhang Soft Matter, 2020,16, 6841-6849

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Pyrrolidines Pyrrolidines
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Pyrrolidines

Comprehensive Guide to Tert-butyl N-[(3aR,6aR)-1,2,3,3a,4,5,6,6a-octahydrocyclopenta[c]pyrrol-4-yl]carbamate (CAS 1228030-08-7)

Tert-butyl N-[(3aR,6aR)-1,2,3,3a,4,5,6,6a-octahydrocyclopenta[c]pyrrol-4-yl]carbamate (CAS 1228030-08-7) is a specialized chiral bicyclic carbamate compound that has gained significant attention in pharmaceutical research and fine chemical synthesis. This structurally unique molecule features a cyclopenta[c]pyrrolidine core with a tert-butoxycarbonyl (Boc) protecting group, making it particularly valuable for asymmetric synthesis and medicinal chemistry applications.

The compound's stereochemical complexity and functional group versatility have made it a subject of interest for researchers investigating novel drug scaffolds and biologically active compounds. Recent trends in AI-assisted drug discovery and computational chemistry have highlighted the importance of such structurally diverse building blocks, as they provide valuable starting points for virtual screening and molecular design.

From a synthetic chemistry perspective, Tert-butyl N-[(3aR,6aR)-octahydrocyclopenta[c]pyrrol-4-yl]carbamate offers several advantages. The Boc-protected amine functionality allows for selective deprotection under mild acidic conditions, while the fused bicyclic system provides rigidity that can influence the three-dimensional orientation of subsequent modifications. These properties make it particularly useful in peptide mimetics development and conformationally restricted analogs of bioactive molecules.

In the context of current pharmaceutical trends, this compound aligns with the growing demand for saturated heterocycles and sp3-rich fragments in drug discovery. The pharmaceutical industry's shift toward three-dimensional molecular architectures has increased the value of such compounds, as they often demonstrate improved target selectivity and metabolic stability compared to flat aromatic systems.

The synthesis of Tert-butyl N-[(3aR,6aR)-1,2,3,3a,4,5,6,6a-octahydrocyclopenta[c]pyrrol-4-yl]carbamate typically involves stereoselective cyclization strategies, often starting from chiral pool materials or through asymmetric catalysis. Recent advances in flow chemistry and continuous processing have opened new possibilities for the scalable production of such complex intermediates.

Analytical characterization of this compound requires specialized techniques due to its structural complexity. Modern LC-MS methods coupled with chiral HPLC are typically employed to verify purity and stereochemical integrity. The development of computational NMR prediction tools has significantly aided in the structural confirmation of such molecules.

From a regulatory perspective, Tert-butyl N-[(3aR,6aR)-octahydrocyclopenta[c]pyrrol-4-yl]carbamate falls into the category of advanced pharmaceutical intermediates. Its use in GMP-compliant synthesis requires thorough documentation of quality control parameters and impurity profiles, especially when intended for clinical trial materials.

The commercial availability of this compound has increased in recent years, reflecting its growing importance in drug discovery pipelines. Suppliers typically offer it in various quantities, from milligram-scale for initial screening to kilogram quantities for process development. The pricing structure often reflects the synthetic complexity and chiral purity requirements.

Future applications of Tert-butyl N-[(3aR,6aR)-1,2,3,3a,4,5,6,6a-octahydrocyclopenta[c]pyrrol-4-yl]carbamate may expand into bioconjugation chemistry and proteolysis targeting chimera (PROTAC) development, where its rigid scaffold could serve as an effective linker between target-binding and E3 ligase-recruiting moieties. The compound's potential in covalent inhibitor design is also being explored by several research groups.

Environmental and safety considerations for handling this material follow standard laboratory protocols for organic compounds. While not classified as hazardous under current regulations, proper personal protective equipment and engineering controls should always be employed when working with any chemical substance.

For researchers considering this compound for their work, several key questions often arise: How does the stereochemistry at the 3a and 6a positions influence biological activity? What are the optimal conditions for Boc deprotection in complex molecular settings? How might this scaffold be incorporated into macrocyclic systems? These are active areas of investigation in contemporary medicinal chemistry.

The patent landscape surrounding Tert-butyl N-[(3aR,6aR)-octahydrocyclopenta[c]pyrrol-4-yl]carbamate derivatives has been growing, particularly in areas of CNS-targeted therapeutics and GPCR modulators. Several pharmaceutical companies have included similar structures in their intellectual property portfolios, indicating the perceived value of this chemotype.

In summary, Tert-butyl N-[(3aR,6aR)-1,2,3,3a,4,5,6,6a-octahydrocyclopenta[c]pyrrol-4-yl]carbamate (CAS 1228030-08-7) represents a valuable chiral building block with diverse applications in modern drug discovery. Its unique structural features and synthetic versatility position it as an important tool for researchers developing next-generation therapeutics and exploring novel chemical space in pharmaceutical development.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)